Congressman urges President Trump to take action on $90,000 multiple sclerosis drug

Rep. Elijah Cummings (D-Md.) urged President Donald Trump to help lower the price of a $90,000-a-year multiple sclerosis drug on Thursday.

In a series of tweets, Cummings said that Trump could “make a deal” on Biogen BIIB, -0.90% and AbbVie’s ABBV, +4.94% Zinbryta, because the drug was developed using technology licensed from the federal government.

“If they refuse, you can revoke their license or license the drug to more companies to lower the price today!” Cummings, who met with Trump to discuss drug prices earlier this year, said in a tweet. “Shouldn’t cost $87k per year!”

>>> Original Source <<<